Overcome direct compression challenges Introducing Kollitab™ DC 87 L The new all-in-one tableting solution with filler, binder, disintegrant and lubricant BASF Pharma Solutions' new coprocessed excipient Kollitab™ DC 87 L is designed to achieve excellent blend, tableting, and flow properties for manufacturing robust and rapidly disintegrating tablets with high content uniformity. » Kollitab™ DC 87 L formulation has high stability and low sensitivity to overblending » Can produce strong tablets across a broad range of compression forces, reducing stress and punch damage on the tablet press, and less tablet defects » Ensures fast tablet disintegration to quickly deliver the intended benefits of the API » " All-in-one " nature enables fast tablet development, simplifies formulation processes, and reduces manufacturing complexity Manufacturing KEY BENEFITS Enables fast tablet development Simplifies formulation development Reduces manufacturing complexity Quality & Regulatory Based on monographed excipients Provides advantages of all-in-one products (reduced Quality Control efforts, handling and documentation) Inspiring Medicines for Better Lives www.pharma.basf.com Request a sample of KollitabTM DC 87 Lhttp://www.pharma.basf.com